Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMO | NYSE
Chart Builder DCF Calculator
$656.02
+$4.57 (+0.70%)
Sep 21, 2026, 11:20 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
44.56B 42.88B 42.86B 44.92B 39.21B 32.22B
Cost of Revenue
27.78B 25.15B 25.66B 25.9B 19.58B 16.19B
Gross Profit
16.78B 17.73B 17.19B 19.01B 19.63B 16.03B
Operating Income
8.11B 7.66B 7.45B 8.53B 10.32B 7.9B
Interest Income
993M 1.08B 879M 272M 43M 65M
Pretax Income
7.27B 7B 6.24B 7.66B 8.84B 7.23B
Net Income
6.74B 6.34B 6B 6.95B 7.73B 6.38B
Selling & General & Admin
7.27B 8.68B 8.41B 9.02B 7.91B 6.95B
Research & Development
1.4B 1.39B 1.34B 1.47B 1.41B 1.18B
Other Expenses
n/a n/a n/a n/a n/a n/a
Operating Expenses
8.67B 10.07B 9.75B 10.49B 9.32B 8.13B
Interest Expense
1.42B 1.65B 1.49B 726M 536M 553M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
36.45B 35.22B 35.41B 36.39B 28.89B 24.32B
Income Tax Expense
547M 657M 284M 703M 1.11B 850M
Shares Outstanding (Basic)
376M 382M 386M 392M 394M 396M
Shares Outstanding (Diluted)
377M 383M 388M 394M 397M 399M
EPS (Basic)
17.77 16.58 15.53 17.73 19.61 16.10
EPS (Diluted)
17.74 16.53 15.45 17.64 19.46 15.98
EBITDA
11.47B 11.8B 11.2B 11.94B 11.97B 10.11B
EBIT
8.69B 8.69B 7.79B 8.56B 9.38B 7.78B
Depreciation & Amortization
2.78B 3.11B 3.41B 3.38B 2.59B 2.33B

© 2026 bestshares.com. All rights reserved.